Melanoma-patient-derived sera induced higher levels of CD163+CD206+ macrophages compared to healthy-donor-derived sera, while HLA-DR and CD86 expression remained unchanged (Figures 3J–3L). The gene discussed is CD163; the disease is melanoma.